Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements
Journal Title: Annals of Hepatology - Year 2016, Vol 15, Issue 1
Abstract
Background. The term early allograft dysfunction (EAD) identifies liver transplant (LT) allografts with initial poor function and portends poor allograft and patient survival. Aims of this study are to use EAD as an intermediate outcome measure in a large single center cohort and identify donor, recipient and peri-operative risk factors. Material and methods. In 1950 consecutive primary LT, donor, recipient and peri-operative data were collected. EAD was defined by the presence of one or more of the following: total bilirubin ≥ 10 mg/dL (171 μmol/L) or, INR ≥ 1.6 on day 7, and ALT/AST > 2,000 IU/L within the first 7 days. Results. The incidence of EAD was 26.5%. 1-, 3-, and 5-year allograft and patient survival for patients who developed EAD were significantly inferior to those who did not (P < 0.01 at all time points). Multivariate analysis demonstrated associations in the development of EAD with recipient pre-operative ventilator status, donation after cardiac death allografts, donor age, allograft size, degree of steatosis, operative time and intra-operative transfusion requirements (all P < 0.01). Patients with EAD had a significantly longer hospitalization at 20.9 ± 38.9 days (median: 9; range: 4-446) compared with 10.7 ± 13.5 days (median: 7; range: 3-231) in patients with no EAD (P < 0.01). Conclusions. This is the largest single center experience demonstrating incidence of EAD and identifying factors associated with development of EAD. EAD is a useful intermediate outcome measure for allograft and patient survival. Balancing recipient pretransplant conditions, donor risk factors and intra-operative conditions are necessary for avoiding EAD.
Authors and Affiliations
David Lee, Kristopher Croome, Jefree Shalev, Kaitlyn Musto, Meenu Sharma, Andrew Keaveny, C. Burcin Taner
Keywords
Related Articles
- EP ID EP78537
- DOI 10.5604/16652681.1184212
- Views 118
- Downloads 0
Older age is associated with increased early mortality after transjugular intrahepatic portosystemic shunt
Introduction & Aim. The role of age as a predictor of mortality after transjugular intra hepatic portosystemic shunt (TIPS) is controversial. Age has been found to be an important predictor of post-TIPS morta...
Hepatogenous diabetes. Current views of an ancient problem
Diabetes developed as a complication of cirrhosis is known as hepatogenous diabetes» (HD). Around 30% to 60% of cirrhotic patients suffer from this metabolic disorder. Insulin resistance in muscular, hepatic and adipose...
Validation of prognostic scores for clinical outcomes in cirrhotic patients with acute variceal bleeding
Background. The Rockall, Glasgow-Blatchford, and AIMS65 are useful and validated scoring systems for predicting the outcomesof patients with nonvariceal gastrointestinal bleeding. However, there are no validated evidenc...
Thyroid-like cholangiocarcinoma of the liver: an unusual morphologic variant with follicular, trabecular and insular patterns
We report the case of a 26-year-old woman with a 19 cm malignant hepatic neoplasm with morphological features that closely resembled a follicular thyroid carcinoma. Despite this, it was interpreted as a cholangiocarcinom...
Idiopathic portal hypertension with multiple hepatic hyperplastic nodules supplied by portal vein